Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 13

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Interactions between nutraceuticals/nutrients and nutrients and therapeutic drugs

Anadón, Arturo, Ares, Irma, Martínez-Larrañaga, María-Rosa, Martínez, María-Aránzazu·2021·Nutraceuticals
DOI 10.1016/b978-0-12-821038-3.00070-7
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-821038-3.00070-7

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 86

  1. Akamine, 2007, Drug-nutrient interactions in elderly people, Curr. Opin. Clin. Nutr. Metab. Care, 10, 204
  2. Albassam, 2017, An appraisal of drug-drug interactions with green tea (Camellia sinensis), Planta Med., 83, 496, 10.1055/s-0043-100934 · DOI
  3. Albert, 1956, Avidity of the tetracyclines for the cations of metals, Nature, 177, 433, 10.1038/177433a0 · DOI · Paper page
  4. Alemdaroglu, 2008, Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability, Biopharm. Drug. Dispos., 29, 335, 10.1002/bdd.617 · DOI
  5. Anadón, 2008, Acute oral safety study of rosemary extracts in rats, J. Food Prot., 71, 790, 10.4315/0362-028X-71.4.790 · DOI
  6. Apitz-Castro, 1983, Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure, Thromb. Res., 32, 155, 10.1016/0049-3848(83)90027-0 · DOI
  7. Asher, 2017, Common herbal dietary supplement-drug interactions, Am. Fam. Physicians, 96, 101
  8. Awang, 1991, Maternal use of ginseng and neonatal androgenization, J. Am. Med. Assoc., 266, 363, 10.1001/jama.1991.03470030063021 · DOI
  9. Bailey, 1998, Grapefruit juice-drug interactions, Br. J. Clin. Pharmacol., 46, 101, 10.1046/j.1365-2125.1998.00764.x · DOI · Paper page
  10. Bares, 2008, Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C, J. Clin. Gastroenterol., 42, 937, 10.1097/MCG.0b013e31815cff36 · DOI
  11. Basu, 2013, Green tea supplementation increases glutathione and plasma antioxidant capacity in adults with the metabolic syndrome, Nutr. Res., 33, 180, 10.1016/j.nutres.2012.12.010 · DOI
  12. Bent, 2006, Saw palmetto for benign prostatic hyperplasia, N. Engl. J. Med., 354, 557, 10.1056/NEJMoa053085 · DOI · Paper page
  13. Bland, 1998, Drug-food interactions, J. Pharm. Soc. Wis., 28, 28
  14. Booth, 1997, Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content, Thromb. Haemost., 77, 503
  15. Borsari, 2001, Silybin, a new iron-chelating agent, J. Inorg. Biochem., 85, 123, 10.1016/S0162-0134(01)00198-2 · DOI
  16. Bressler, 2005, Herb-drug interactions: interactions between saw palmetto and prescription medications, Geriatrics, 60, 32
  17. Bressler, 2006, Grapefruit juice and prescription drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs, Geriatrics, 61, 12
  18. Bressler, 2003, Principles of drug therapy for the elderly patient, Mayo Clin. Proc., 78, 1564, 10.4065/78.12.1564 · DOI
  19. Brownie, 2006, Why are elderly individuals at risk of nutritional deficiency?, Int. J. Nurs. Pract., 12, 110, 10.1111/j.1440-172X.2006.00557.x · DOI · Paper page
  20. Bryer-Ash, 1987, Torsades de pointes precipitated by a Chinese herbal remedy, Am. J. Cardiol., 60, 1186, 10.1016/0002-9149(87)90421-8 · DOI
  21. Butterweck, 2007, St John’s wort: role of active compounds for its mechanism of action and efficacy, Wien. Med. Wochenschr., 157, 356, 10.1007/s10354-007-0440-8 · DOI
  22. Chitturi, 2008, Hepatotoxic slimming aids and other herbal hepatotoxins, J. Gastroenterol. Hepatol., 23, 366, 10.1111/j.1440-1746.2008.05310.x · DOI
  23. Chow, 2008, Liver failure associated with the use of black cohosh for menopausal symptoms, Med. J. Aust., 188, 420, 10.5694/j.1326-5377.2008.tb01691.x · DOI
  24. Cordon-Cardo, 1989, Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites, Proc. Natl. Acad. Sci. USA, 86, 695, 10.1073/pnas.86.2.695 · DOI · Paper page
  25. Dai, 2007, Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature, World J. Gastroenterol., 13, 1628, 10.3748/wjg.v13.i10.1628 · DOI
  26. Dasgupta, 2003, Review of abnormal laboratory test results and toxic effects due to use of herbal medicines, Am. J. Clin. Pathol., 120, 127, 10.1309/P024K7VRDDPJCTVN · DOI
  27. Deferme, 2003, The effect of food components on the absorption of P-gp substrates: a review, J. Pharm. Pharmacol., 55, 153, 10.1211/002235702603 · DOI
  28. De Smet, 1994, Potential risks of health food products containing yohimbe extracts (letter), Br. Med. J., 309, 958, 10.1136/bmj.309.6959.958 · DOI
  29. Dreier, 2004, Statin-associated rhabdomyolysis triggered by grapefruit consumption, Neurology, 62, 670, 10.1212/WNL.62.4.670 · DOI · Paper page
  30. Dresser, 2002, Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral bioavailability of fexofenadine, Clin. Pharmacol. Ther., 71, 11, 10.1067/mcp.2002.121152 · DOI · Paper page
  31. Durcharme, 1995, Disposition of intravenous and oral cyclosporine after administration with grapefruit juice, Clin. Pharmacol. Ther., 57, 485, 10.1016/0009-9236(95)90032-2 · DOI · Paper page
  32. Durr, 2000, St John’s wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4, Clin. Pharmacol. Ther., 68, 598, 10.1067/mcp.2000.112240 · DOI · Paper page
  33. German, 1995, Garlic and the risk of TURP bleeding, Br. J. Urol., 76, 518, 10.1111/j.1464-410X.1995.tb07766.x · DOI
  34. Gertz, 2004, Review about Ginkgo biloba special extract EGb 761 (Ginkgo), Curr. Pharm. Des., 10, 261, 10.2174/1381612043386437 · DOI
  35. Gorski, 2004, The effect of Echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo, Clin. Pharmacol. Ther., 75, 89, 10.1016/j.clpt.2003.09.013 · DOI · Paper page
  36. Gurley, 2015, Multi-ingredient, caffeine containing dietary supplements: history, safety, and efficacy, Clin. Ther., 37, 275, 10.1016/j.clinthera.2014.08.012 · DOI
  37. Gurley, 2018, Clinically relevant herb-micronutrient interactions: when botanicals, minerals, and vitamins collide, Adv. Nutr., 9, 524S, 10.1093/advances/nmy029 · DOI
  38. Ha, 1995, Metabolism of theophylline by cDNA-expressed human cytochromes P450, Br. J. Clin. Pharmacol., 39, 321, 10.1111/j.1365-2125.1995.tb04455.x · DOI
  39. Hedenmalm, 2002, Glucose intolerance with atypical antipsychotics, Drug. Saf., 25, 1107, 10.2165/00002018-200225150-00005 · DOI
  40. Ho, 2005, Transporters and drug therapy: implications for drug disposition and disease, Clin. Pharmacol. Ther., 78, 260, 10.1016/j.clpt.2005.05.011 · DOI · Paper page
  41. Hoffbrand, 1968, Mechanism of folate deficiency in patients receiving phenytoin, Lancet, 292, 528, 10.1016/S0140-6736(68)92404-5 · DOI
  42. Izzat, 1998, A taste of Chinese medicine!, Ann. Thorac. Surg., 66, 941, 10.1016/S0003-4975(98)00624-9 · DOI
  43. Kleijnen, 1992, Ginkgo biloba, Lancet, 340, 1136, 10.1016/0140-6736(92)93158-J · DOI · Paper page
  44. Knop, 2015, Inhibitory effects of green tea and (–)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein, PLoS One, 10, e0139370, 10.1371/journal.pone.0139370 · DOI
  45. Koch-Weser, 1971, Drug interactions with coumarin anticoagulant, N. Engl. J. Med., 285, 547, 10.1056/NEJM197109022851005 · DOI
  46. Koudriakowa, 1988, Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir, Drug. Metab. Dispos., 26, 552
  47. Kronbach, 1988, Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the mayor cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs, Clin. Pharmacol. Ther., 43, 630, 10.1038/clpt.1988.87 · DOI · Paper page
  48. Lee, 2008, Possible differential induction of phase 2 enzyme and antioxidant pathways by American ginseng, Panax quinquefolius, J. Clin. Pharmacol., 48, 599, 10.1177/0091270008314252 · DOI
  49. Leibovitch, 2004, Food-drug interaction: careful drug selection and patients counseling can reduce the risk in older patients, Geriatrics, 59, 19
  50. Levine, 1968, Steatorrhea induced by para-aminosalycilic acid, Ann. Inter. Med., 68, 1265, 10.7326/0003-4819-68-6-1265 · DOI
  51. Lowe, 2005, Herbal aconite tea and refractory ventricular tachycardia, N. Engl. J. Med., 353, 1532, 10.1056/NEJMc051568 · DOI
  52. Lown, 1997, Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine, Clin. Pharmacol. Ther., 62, 248, 10.1016/S0009-9236(97)90027-8 · DOI · Paper page
  53. Lown, 1997, Grapefruit juice increases felodipine oral availability in human by decreasing intestinal CYP3A protein expression, J. Clin. Invest., 99, 2545, 10.1172/JCI119439 · DOI · Paper page
  54. Liu, 2019, Statins: adverse reactions, oxidative stress and metabolic interactions, Pharmacol. Ther., 195, 54, 10.1016/j.pharmthera.2018.10.004 · DOI
  55. Lundahl, 1995, Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects, Eur. J. Clin. Pharmacol., 49, 61, 10.1007/BF00192360 · DOI
  56. Mansoor, 2001, Herbs and alternative therapies in the hypertension clinic, Am. J. Hypertens., 14, 971, 10.1016/S0895-7061(01)02172-0 · DOI
  57. Mashour, 1998, Herbal medicine for the treatment of cardiovascular disease: clinical considerations, Arch. Intern. Med., 158, 2225, 10.1001/archinte.158.20.2225 · DOI · Paper page
  58. Misaka, 2014, Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects, Clin. Pharmacol. Ther., 95, 432, 10.1038/clpt.2013.241 · DOI
  59. Neary, 1999, Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes, Brain Res., 816, 358, 10.1016/S0006-8993(98)01126-3 · DOI
  60. Olukoga, 2000, Liquorice and its health implications, J. R. Soc. Health, 120, 83, 10.1177/146642400012000203 · DOI
  61. Paine, 2006, A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction, Am. J. Clin. Nutr., 83, 1097, 10.1093/ajcn/83.5.1097 · DOI
  62. Plouzek, 1999, Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract, Eur. J. Cancer, 35, 1541, 10.1016/S0959-8049(99)00180-X · DOI
  63. Reuter, 1995, Allium sativum and Allium ursinum: part 2—pharmacology and medicinal application, Phytomedicine, 2, 73, 10.1016/S0944-7113(11)80052-8 · DOI
  64. Rose, 1990, Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report, Neurosurgery, 26, 880, 10.1227/00006123-199005000-00026 · DOI
  65. Saito, 2005, Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies, Drug. Saf., 28, 677, 10.2165/00002018-200528080-00003 · DOI
  66. Samman, 2001, Green tea or rosemary extract added to foods reduces nonheme-iron absorption, Am. J. Clin. Nutr., 73, 607, 10.1093/ajcn/73.3.607 · DOI
  67. Santos, 2005, An approach to evaluating drug-nutrient interactions, Pharmacotherapy, 25, 1789, 10.1592/phco.2005.25.12.1789 · DOI
  68. Schmidt, 2002, Food-drug interactions, Drugs, 62, 1481, 10.2165/00003495-200262100-00005 · DOI · Paper page
  69. Seeff, 2007, Herbal hepatotoxicity, Clin. Liver Dis., 11, 577, 10.1016/j.cld.2007.06.005 · DOI
  70. Shelton, 2009, St John’s wort (Hypericum perforatum) in major depression, J. Clin. Psychiatr., 70, 23, 10.4088/JCP.8157su1c.05 · DOI
  71. Siegel, 1979, Ginseng abuse syndrome: problems with the panacea, J. Am. Med. Assoc., 241, 1614, 10.1001/jama.1979.03290410046024 · DOI
  72. Soldner, 1999, Grapefruit juice activates P-glycoprotein-mediated drug transport, Pharm. Res., 16, 478, 10.1023/A:1011902625609 · DOI
  73. Sung, 2000, Effects of red ginseng upon vascular endothelial function in patients with essential hypertension, Am. J. Chin. Med., 28, 205, 10.1142/S0192415X00000258 · DOI
  74. Tam, 2001, Yohimbine: a clinical review, Pharmacol. Ther., 91, 215, 10.1016/S0163-7258(01)00156-5 · DOI
  75. Tauchert, 2002, Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure, Am. Heart J., 143, 910, 10.1067/mhj.2002.121463 · DOI
  76. Turner, 2005, An evaluation of Echinacea angustifolia in experimental rhinovirus infections, N. Engl. J. Med., 353, 341, 10.1056/NEJMoa044441 · DOI
  77. Wacher, 1995, Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy, Mol. Carcinog., 13, 129, 10.1002/mc.2940130302 · DOI · Paper page
  78. Walker, 1994, Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess, Endocrinol. Metab. Clin. North. Am., 23, 359, 10.1016/S0889-8529(18)30102-6 · DOI
  79. Walker, 1966, Tyramine content of previously restricted foods in monoamine oxidase inhibitor diets, J. Clin. Psychopharmacol., 16, 383, 10.1097/00004714-199610000-00007 · DOI
  80. Wallace, 2002, Is it really OK to take this with food? Old Interactions with a new twist, J. Clin. Pharmacol., 42, 437, 10.1177/00912700222011364 · DOI
  81. Wandel, 1999, P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies, Cancer Res., 59, 3944
  82. Werba, 2008, The effect of green tea on simvastatin tolerability, Ann. Intern. Med., 149, 286, 10.7326/0003-4819-149-4-200808190-00019 · DOI
  83. Yeu, 2007, Saw palmetto and intraoperative floppy-iris syndrome, J. Cataract. Refract. Surg., 33, 927, 10.1016/j.jcrs.2006.12.032 · DOI
  84. Yin, 2004, Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole, Pharmacogen, 14, 841, 10.1097/00008571-200412000-00007 · DOI
  85. Zhou, 2004, Herbal modulation of P-glycoprotein, Drug. Metab. Rev., 36, 57, 10.1081/DMR-120028427 · DOI · Paper page
  86. Zou, 1989, Effect of motherwort on blood hyperviscosity, Am. J. Chin. Med., 10.1142/S0192415X89000115 · DOI

Cited by

See all 13

Metadata

Authors
Anadón, A., Ares, I., Martínez-Larrañaga, M.-R., & Martínez, M.-A.
Venue
Nutraceuticals
Publisher
Elsevier
Published
2021
Pages
1175-1197
DOI
10.1016/b978-0-12-821038-3.00070-7
Cited by
13
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.